Saysumthinfunnymike
VOTE!!!
But that said, everyone needs to make their own decisions in here obviously, all we are here to do is kick knowledge, I appreciate everyone doing their own DD..
I'm a historical facts nerd breh don't mind me lol. I'm in IPOC as well. Biden is going to push for lowering the eligibility to 60+ and expanding Medicare Advantage which is another bullish case. Fact Sheet: How Joe Biden Would Help You Get Health Insurance Coverage During the Coronavirus Crisis | Joe Biden for President: Official Campaign Website@Arithmetic A SPAC deal like that is not unusual. Tilman owned LCA which is merging with Golden Nugget. He was in control of the entire thing which was known from the beginning and all it told me as an investor was that the deal was quite obviously going to get done since Tilman was working both sides. Some call it shady, call it what you will but the confidence for me to invest was at 100% in part because of that and then you look a few months later and it's up over 100%
As for IPOC the bullish case is solely because the sector is hot and SPACs are hot and Chameth has been on a roll (the man behind SPCE, IPOB, etc. )
You aren't investing in Clover Health, you are investing in the idea that Chameth + the sector will allow it to run...
IPOD/IPOE/IPOF are all at the same price or higher than IPOC WITHOUT a target.@Arithmetic A SPAC deal like that is not unusual. Tilman owned LCA which is merging with Golden Nugget. He was in control of the entire thing which was known from the beginning and all it told me as an investor was that the deal was quite obviously going to get done since Tilman was working both sides. Some call it shady, call it what you will but the confidence for me to invest was at 100% in part because of that and then you look a few months later and it's up over 100%
As for IPOC the bullish case is solely because the sector is hot and SPACs are hot and Chameth has been on a roll (the man behind SPCE, IPOB, etc. )
You aren't investing in Clover Health, you are investing in the idea that Chameth + the sector will allow it to run...
IPOD/IPOE/IPOF are all at the same price or higher than IPOC WITHOUT a target.
I’ve got money parked in all of them with hopes that Chamath finds more appealing target than he did with IPOC.
This weekend I was doing some DD on IPOC.
When I started I thought IPOC was going to end up being one of my high-conviction stocks, but now I might stay away.
My first big concern is the management team: they might be under investigation. The CEO, Vivek Garipalli, and his partners also own a company that has three hospitals. Apparently, they are accused of embezzling $169 million, and falsifying the books. New Jersey state officials condemned their actions, but haven't yet recommended a criminal investigation. They also have a civil case going.
NJ legislators call for probe of insurance unicorn - MedCity News
Once I read that, I re-read the investor documents with a lot more skepticism.
Now, I don't see anything innovative about the company. The claims about the Clover Assistant, which doctor's use to provide service to patients, just does not sound innovative. They only have 57 thousand members, most of which they probably got through their three hospitals in NJ. From where are they getting Big Data? Medical information is highly protected.
They are overwhelmingly based in NJ. They haven't been able to scale.
I just don't see how they are going to take on the big boys in insurance and health care,which have millions of patients from which to draw data.
They try to position themselves as a tech company, and they use all of the Silicon Valley buzzwords, but if their technology is so advanced, why aren't they planning to sell to all doctors and hospitals? If you can cut doctor's paperwork per patient from 16 minutes down to 5, why aren't you selling your tech?
This might be a decent momentum play, but I don't see a disruptive company.
What am I missing? After all, I am a newb, and I ain't a medical professional.
The management team seems shady. They might leave after the big payday.
I won't be surprised if this acquisition gets cancelled. I can see the shareholders being a bit skeptical.
BFT got all the YouTubers discussing it now. IPOC is still a bit more under the radar in those circles but I can't complain with my $10.60 average. I think some big money will eventually get in
I bought some shares a while back just for a quick flip. Looking to sell those later this week.
Will still barely be part of triple digit Tesla gang.
I came across this a few weeks back and I kinda just shrugged it off. A lot of companies and business owners have "fraud" linked to them. Sometimes there is, sometimes there isn't. I know from personal experience not to look into the accusations too closely.This weekend I was doing some DD on IPOC.
When I started I thought IPOC was going to end up being one of my high-conviction stocks, but now I might stay away.
My first big concern is the management team: they might be under investigation. The CEO, Vivek Garipalli, and his partners also own a company that has three hospitals. Apparently, they are accused of embezzling $169 million, and falsifying the books. New Jersey state officials condemned their actions, but haven't yet recommended a criminal investigation. They also have a civil case going.
NJ legislators call for probe of insurance unicorn - MedCity News
Once I read that, I re-read the investor documents with a lot more skepticism.
Now, I don't see anything innovative about the company. The claims about the Clover Assistant, which doctor's use to provide service to patients, just does not sound innovative. They only have 57 thousand members, most of which they probably got through their three hospitals in NJ. From where are they getting Big Data? Medical information is highly protected.
They are overwhelmingly based in NJ. They haven't been able to scale.
I just don't see how they are going to take on the big boys in insurance and health care,which have millions of patients from which to draw data.
They try to position themselves as a tech company, and they use all of the Silicon Valley buzzwords, but if their technology is so advanced, why aren't they planning to sell to all doctors and hospitals? If you can cut doctor's paperwork per patient from 16 minutes down to 5, why aren't you selling your tech?
This might be a decent momentum play, but I don't see a disruptive company.
What am I missing? After all, I am a newb, and I ain't a medical professional.
The management team seems shady. They might leave after the big payday.
I won't be surprised if this acquisition gets cancelled. I can see the shareholders being a bit skeptical.